Mikael Lönn

Filings at 4 companies/Board member · Annexin Pharmaceuticals AB (publ)

5 of 6 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 6. Reading the whole list, and the full company page behind every filing, is part of the subscription. So are this filer’s key figures — how many filings and open-market purchases they reported, and over which period — and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The 5 most recent of 6 visible filings, newest first.

Annexin Pharmaceuticals AB (publ) Board member
5,231,736 SEKGrant
TradedJul 7, 2026FiledJul 8, 2026
Genovis AB Board member
6,519,152 SEKOpen-market sale
TradedMay 22, 2025FiledMay 23, 2025
Annexin Pharmaceuticals AB (publ) Board member
12,975,539 SEKGrant
TradedMar 24, 2025FiledMar 24, 2025
Genovis AB Board member
5,992,500 SEKOpen-market sale
TradedMar 5, 2025FiledMar 7, 2025
Genovis AB Board member
26,625,000 SEKOpen-market sale
TradedAug 28, 2023FiledAug 28, 2023